Global Multiple Sclerosis Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • receipt Report ID : 153360
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 123
  • list Pharmaceuticals and Healthcare

Multiple sclerosis (MS) is a demyelinating disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged. This damage disrupts the ability of parts of the nervous system to communicate, resulting in a range of signs and symptoms, including physical, mental, and sometimes psychiatric problems.

Scope of the Report:

The worldwide market for Multiple Sclerosis Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

This report focuses on the Multiple Sclerosis Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

Biogen

Sanofi

Novartis

Teva

Merck KGaA

Bayer

ACORDA

Mallinckrodt

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Injectable medications

Oral medications

Infused medications

Market Segment by Applications, can be divided into

Relapsing forms of MS

Improve walking in patients with MS

There are 15 Chapters to deeply display the global Multiple Sclerosis Drugs market.

Chapter 1, to describe Multiple Sclerosis Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Multiple Sclerosis Drugs, with sales, revenue, and price of Multiple Sclerosis Drugs, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Multiple Sclerosis Drugs, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Multiple Sclerosis Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Multiple Sclerosis Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Multiple Sclerosis Drugs Introduction

1.2 Market Analysis by Type

1.2.1 Injectable medications

1.2.2 Oral medications

1.2.3 Infused medications

1.3 Market Analysis by Applications

1.3.1 Relapsing forms of MS

1.3.2 Improve walking in patients with MS

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Biogen

2.1.1 Business Overview

2.1.2 Multiple Sclerosis Drugs Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Biogen Multiple Sclerosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Sanofi

2.2.1 Business Overview

2.2.2 Multiple Sclerosis Drugs Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Sanofi Multiple Sclerosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Novartis

2.3.1 Business Overview

2.3.2 Multiple Sclerosis Drugs Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Novartis Multiple Sclerosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Teva

2.4.1 Business Overview

2.4.2 Multiple Sclerosis Drugs Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Teva Multiple Sclerosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Merck KGaA

2.5.1 Business Overview

2.5.2 Multiple Sclerosis Drugs Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Merck KGaA Multiple Sclerosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Bayer

2.6.1 Business Overview

2.6.2 Multiple Sclerosis Drugs Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Bayer Multiple Sclerosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 ACORDA

2.7.1 Business Overview

2.7.2 Multiple Sclerosis Drugs Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 ACORDA Multiple Sclerosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Mallinckrodt

2.8.1 Business Overview

2.8.2 Multiple Sclerosis Drugs Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Mallinckrodt Multiple Sclerosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Multiple Sclerosis Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Multiple Sclerosis Drugs Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Multiple Sclerosis Drugs Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Multiple Sclerosis Drugs Manufacturer Market Share in 2017

3.3.2 Top 6 Multiple Sclerosis Drugs Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Multiple Sclerosis Drugs Market Analysis by Regions

4.1 Global Multiple Sclerosis Drugs Sales, Revenue and Market Share by Regions

4.1.1 Global Multiple Sclerosis Drugs Sales and Market Share by Regions (2013-2018)

4.1.2 Global Multiple Sclerosis Drugs Revenue and Market Share by Regions (2013-2018)

4.2 North America Multiple Sclerosis Drugs Sales and Growth Rate (2013-2018)

4.3 Europe Multiple Sclerosis Drugs Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Multiple Sclerosis Drugs Sales and Growth Rate (2013-2018)

4.5 South America Multiple Sclerosis Drugs Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Multiple Sclerosis Drugs Sales and Growth Rate (2013-2018)

5 North America Multiple Sclerosis Drugs by Countries

5.1 North America Multiple Sclerosis Drugs Sales, Revenue and Market Share by Countries

5.1.1 North America Multiple Sclerosis Drugs Sales and Market Share by Countries (2013-2018)

5.1.2 North America Multiple Sclerosis Drugs Revenue and Market Share by Countries (2013-2018)

5.2 United States Multiple Sclerosis Drugs Sales and Growth Rate (2013-2018)

5.3 Canada Multiple Sclerosis Drugs Sales and Growth Rate (2013-2018)

5.4 Mexico Multiple Sclerosis Drugs Sales and Growth Rate (2013-2018)

6 Europe Multiple Sclerosis Drugs by Countries

6.1 Europe Multiple Sclerosis Drugs Sales, Revenue and Market Share by Countries

6.1.1 Europe Multiple Sclerosis Drugs Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Multiple Sclerosis Drugs Revenue and Market Share by Countries (2013-2018)

6.2 Germany Multiple Sclerosis Drugs Sales and Growth Rate (2013-2018)

6.3 UK Multiple Sclerosis Drugs Sales and Growth Rate (2013-2018)

6.4 France Multiple Sclerosis Drugs Sales and Growth Rate (2013-2018)

6.5 Russia Multiple Sclerosis Drugs Sales and Growth Rate (2013-2018)

6.6 Italy Multiple Sclerosis Drugs Sales and Growth Rate (2013-2018)

7 Asia-Pacific Multiple Sclerosis Drugs by Countries

7.1 Asia-Pacific Multiple Sclerosis Drugs Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Multiple Sclerosis Drugs Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Multiple Sclerosis Drugs Revenue and Market Share by Countries (2013-2018)

7.2 China Multiple Sclerosis Drugs Sales and Growth Rate (2013-2018)

7.3 Japan Multiple Sclerosis Drugs Sales and Growth Rate (2013-2018)

7.4 Korea Multiple Sclerosis Drugs Sales and Growth Rate (2013-2018)

7.5 India Multiple Sclerosis Drugs Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Multiple Sclerosis Drugs Sales and Growth Rate (2013-2018)

8 South America Multiple Sclerosis Drugs by Countries

8.1 South America Multiple Sclerosis Drugs Sales, Revenue and Market Share by Countries

8.1.1 South America Multiple Sclerosis Drugs Sales and Market Share by Countries (2013-2018)

8.1.2 South America Multiple Sclerosis Drugs Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Multiple Sclerosis Drugs Sales and Growth Rate (2013-2018)

8.3 Argentina Multiple Sclerosis Drugs Sales and Growth Rate (2013-2018)

8.4 Colombia Multiple Sclerosis Drugs Sales and Growth Rate (2013-2018)

9 Middle East and Africa Multiple Sclerosis Drugs by Countries

9.1 Middle East and Africa Multiple Sclerosis Drugs Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Multiple Sclerosis Drugs Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Multiple Sclerosis Drugs Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Multiple Sclerosis Drugs Sales and Growth Rate (2013-2018)

9.3 UAE Multiple Sclerosis Drugs Sales and Growth Rate (2013-2018)

9.4 Egypt Multiple Sclerosis Drugs Sales and Growth Rate (2013-2018)

9.5 Nigeria Multiple Sclerosis Drugs Sales and Growth Rate (2013-2018)

9.6 South Africa Multiple Sclerosis Drugs Sales and Growth Rate (2013-2018)

10 Global Multiple Sclerosis Drugs Market Segment by Type

10.1 Global Multiple Sclerosis Drugs Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Multiple Sclerosis Drugs Sales and Market Share by Type (2013-2018)

10.1.2 Global Multiple Sclerosis Drugs Revenue and Market Share by Type (2013-2018)

10.2 Injectable medications Sales Growth and Price

10.2.1 Global Injectable medications Sales Growth (2013-2018)

10.2.2 Global Injectable medications Price (2013-2018)

10.3 Oral medications Sales Growth and Price

10.3.1 Global Oral medications Sales Growth (2013-2018)

10.3.2 Global Oral medications Price (2013-2018)

10.4 Infused medications Sales Growth and Price

10.4.1 Global Infused medications Sales Growth (2013-2018)

10.4.2 Global Infused medications Price (2013-2018)

11 Global Multiple Sclerosis Drugs Market Segment by Application

11.1 Global Multiple Sclerosis Drugs Sales Market Share by Application (2013-2018)

11.2 Relapsing forms of MS Sales Growth (2013-2018)

11.3 Improve walking in patients with MS Sales Growth (2013-2018)

12 Multiple Sclerosis Drugs Market Forecast (2018-2023)

12.1 Global Multiple Sclerosis Drugs Sales, Revenue and Growth Rate (2018-2023)

12.2 Multiple Sclerosis Drugs Market Forecast by Regions (2018-2023)

12.2.1 North America Multiple Sclerosis Drugs Market Forecast (2018-2023)

12.2.2 Europe Multiple Sclerosis Drugs Market Forecast (2018-2023)

12.2.3 Asia-Pacific Multiple Sclerosis Drugs Market Forecast (2018-2023)

12.2.4 South America Multiple Sclerosis Drugs Market Forecast (2018-2023)

12.2.5 Middle East and Africa Multiple Sclerosis Drugs Market Forecast (2018-2023)

12.3 Multiple Sclerosis Drugs Market Forecast by Type (2018-2023)

12.3.1 Global Multiple Sclerosis Drugs Sales Forecast by Type (2018-2023)

12.3.2 Global Multiple Sclerosis Drugs Market Share Forecast by Type (2018-2023)

12.4 Multiple Sclerosis Drugs Market Forecast by Application (2018-2023)

12.4.1 Global Multiple Sclerosis Drugs Sales Forecast by Application (2018-2023)

12.4.2 Global Multiple Sclerosis Drugs Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Multiple Sclerosis Drugs Picture

Table Product Specifications of Multiple Sclerosis Drugs

Figure Global Sales Market Share of Multiple Sclerosis Drugs by Types in 20

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery